These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2517445)

  • 21. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
    Yoshida M; Nakanishi T; Komatsu Y
    Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRH and spinocerebellar degeneration.
    LeWitt PA; Ehrenkranz JR
    Lancet; 1982 Oct; 2(8305):981. PubMed ID: 6127475
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuropathology of late cortical cerebellar atrophy in Japan: distribution of cerebellar change on an autopsy case and review of Japanese cases.
    Tsuchiya K; Ozawa E; Saito F; Irie H; Mizutani T
    Eur Neurol; 1994; 34(5):253-62. PubMed ID: 7995299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
    Sobue I; Yamamoto H; Konagaya M; Iida M; Takayanagi T
    Lancet; 1980 Feb; 1(8165):418-9. PubMed ID: 6101863
    [No Abstract]   [Full Text] [Related]  

  • 25. [Single photon emission computed tomograph using 99mTc-hexamethyl-propyleneamine oxime in spinocerebellar degeneration].
    Ono S; Fukunaga M; Morita K; Otsuka N; Nagai K; Rui W; Furukawa T; Muranaka A; Yanagimoto S; Tomomitsu T
    Kaku Igaku; 1988 Mar; 25(3):243-53. PubMed ID: 3135426
    [No Abstract]   [Full Text] [Related]  

  • 26. A neuroendocrinological study of responders and non-responders to ceruletide treatment in chronic neuroleptic-resistant schizophrenia.
    Moroji T; Okuyama T; Tsunashima K; Matsuzaki I
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):49-64. PubMed ID: 2885895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of spinocerebellar degeneration with emphasis on TRH].
    Takayanagi T
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1331-2. PubMed ID: 9128397
    [No Abstract]   [Full Text] [Related]  

  • 28. Intrathecal baclofen pump in spinocerebellar degeneration.
    Ramnarayan R; Herculus S
    Neurol India; 2016; 64(6):1354-1355. PubMed ID: 27841225
    [No Abstract]   [Full Text] [Related]  

  • 29. Antidepressant effect of thyrotropin-releasing hormone (TRH) and the plasma thyrotropin levels in depression.
    Takahashi S; Kondo H; Yoshimura M; Ochi Y
    Folia Psychiatr Neurol Jpn; 1973; 27(4):305-14. PubMed ID: 4205643
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the hypothalamic-pituitary dopaminergic system in Parkinson's disease and spinocerebellar degeneration. Response to TRH and sulpiride].
    Joshita Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):59-66. PubMed ID: 3106541
    [No Abstract]   [Full Text] [Related]  

  • 31. [TRH stimulation test in hereditary ataxia].
    Lufei HQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Jun; 20(3):154-6. PubMed ID: 3115733
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cerebellin in the cerebellum in spinocerebellar degeneration].
    Mizuno Y; Takahashi K; Totsune K; Ohneda M; Konno H; Murakami O; Satoh F; Sone M; Takase S; Itoyama Y
    No To Shinkei; 1995 Nov; 47(11):1069-74. PubMed ID: 7495612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinocerebellar degenerations--clinical aspects and new treatment of ataxia.
    Sobue I
    Jpn J Med; 1985 Feb; 24(1):62-7. PubMed ID: 3923240
    [No Abstract]   [Full Text] [Related]  

  • 34. [New therapeutic possiblities in depression: the thyrotropin releasing hormone factor].
    López-Ibor Aliño JJ; Ayuso Gutiérrez JL; Montejo Iglesias L; Hernández Herreros M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1974 Mar; 2(2):91-102. PubMed ID: 4211532
    [No Abstract]   [Full Text] [Related]  

  • 35. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.
    Kastin AJ; Ehrensing RH; Schalch DS; Anderson MS
    Lancet; 1972 Oct; 2(7780):740-2. PubMed ID: 4116150
    [No Abstract]   [Full Text] [Related]  

  • 36. Thyrotropin-releasing hormone in the treatment of intractable epilepsy.
    Kubek MJ; Garg BP
    Pediatr Neurol; 2002 Jan; 26(1):9-17. PubMed ID: 11814729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.
    van der Vis-Melsen MJ; Weiner JD
    Lancet; 1972 Dec; 2(7792):1415. PubMed ID: 4118700
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyrotropin-releasing hormone and dementia.
    Sunderland T; Mellow AM; Gross M; Cohen RM; Tariot PN; Newhouse PA; Murphy DL
    Am J Psychiatry; 1986 Oct; 143(10):1318. PubMed ID: 3094388
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of endogenous depression with oral thyrotropin-releasing hormone and amitriptyline.
    Karlberg BE; Kjellman BF; Kågedal B
    Acta Psychiatr Scand; 1978 Nov; 58(5):389-400. PubMed ID: 102114
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical observations on therapeutic applications of thyrotropin-releasing hormone (TRH).
    Sakoda M; Mori H; Yamada A; Kusaka T; Tateiwa M
    Kobe J Med Sci; 1974 Jun; 20(2):65-81. PubMed ID: 4218287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.